Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022

被引：0
|
作者：
Modes, Matthew E. [1 ]
Directo, Michael P. [2 ]
Melgar, Michael [3 ]
Johnson, Lily R. [2 ]
Yang, Haoshu [2 ]
Chaudhary, Priya [2 ]
Bartolini, Susan [2 ]
Kho, Norling [2 ]
Noble, Paul W. [1 ]
Isonaka, Sharon [2 ]
Chen, Peter [1 ]
机构：
[1] Cedars Sinai Med Ctr, Dept Med, Womens Guild Lung Inst, Los Angeles, CA 90048 USA
[2] Cedars Sinai Med Ctr, Clin Efficiency & Value, Los Angeles, CA 90048 USA
[3] CDC, COVID 19 Emergency Response Team, Atlanta, GA 30333 USA
来源：
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT | 2022年 / 71卷 / 06期
关键词：
reverse transcription-polymerase chain reaction (RT-PCR); SEVERITY; DISEASE; STATES;
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：217 / 223
页数：7
相关论文
共 14 条
  • [1] Genomic Surveillance for SARS-CoV-2 Variants: Predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) Variants - United States, June 2021-January 2022
    Lambrou, Anastasia S.
    Shirk, Philip
    Steele, Molly K.
    Paul, Prabasaj
    Paden, Clinton R.
    Cadwell, Betsy
    Reese, Heather E.
    Aoki, Yutaka
    Hassell, Norman
    Zheng, Xiao-Yu
    Talarico, Sarah
    Chen, Jessica C.
    Oberste, M. Steven
    Batra, Dhwani
    McMullan, Laura K.
    Halpin, Alison Laufer
    Galloway, Summer E.
    MacCannell, Duncan R.
    Kondor, Rebecca
    Barnes, John
    MacNeil, Adam
    Silk, Benjamin J.
    Dugan, Vivien G.
    Scobie, Heather M.
    Wentworth, David E.
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2022, 71 (06): : 206 - 211
  • [2] Genomic Surveillance for SARS-CoV-2 Variants: Predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) Variants - United States, June 2021-January 2022 (vol 71, 2022)
    Lambrou, Anastasia S.
    Shirk, Philip
    Steele, Molly K.
    Paul, Prabasaj
    Paden, Clinton R.
    Cadwell, Betsy
    Reese, Heather E.
    Aoki, Yutaka
    Hassell, Norman
    Caravas, Jason
    Kovacs, Nicholas A.
    Gerhart, Jonathan G.
    Ng, Han Jia
    Zheng, Xiao-yu
    Beck, Andrew
    Chau, Reina
    Cintron, Roxana
    Cook, Peter W.
    Gulvik, Christopher A.
    Howard, Dakota
    Jang, Yunho
    Knipe, Kristen
    Lacek, Kristine A.
    Moser, Kara A.
    Paskey, Adrian C.
    Rambo-Martin, Benjamin L.
    Nagilla, Roopa R.
    Retchless, Adam C.
    Schmerer, Matthew W.
    Seby, Sandra
    Shepard, Samuel S.
    Stanton, Richard A.
    Stark, Thomas J.
    Uehara, Anna
    Unoarumhi, Yvette
    Bentz, Meghan L.
    Burgin, Alex
    Burroughs, Mark
    Davis, Morgan L.
    Keller, Matthew W.
    Keong, Lisa M.
    Le, Shoshona S.
    Lee, Justin S.
    Madden, Joseph C., Jr.
    Nobles, Sarah
    Owuor, D. Collins
    Padilla, Jasmine
    Sheth, Mili
    Wilson, Malania M.
    Talarico, Sarah
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2022, 71 (14): : 528 - 528
  • [3] SARS-CoV-2 Infection and Hospitalization Among Adults Aged ≥18Years, by Vaccination Status, Before and During SARS-CoV-2 B.1.1.529 (Omicron) Variant Predominance - Los Angeles County, California, November 7, 2021-January 8, 2022
    Danza, Phoebe
    Koo, Tae Hee
    Haddix, Meredith
    Fisher, Rebecca
    Traub, Elizabeth
    OYong, Kelsey
    Balter, Sharon
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2022, 71 (05): : 177 - 181
  • [4] Risk factors associated with mortality in hospitalized patients with laboratory confirmed SARS-CoV-2 infection during the period of omicron (B.1.1.529) variant predominance
    O'Leary, Ashley L.
    Wattengel, Bethany A.
    Carter, Michael T.
    Drye, Alexandra F.
    Mergenhagen, Kari A.
    AMERICAN JOURNAL OF INFECTION CONTROL, 2023, 51 (06) : 603 - 606
  • [5] Severity of Disease Among Adults Hospitalized with Laboratory-Confirmed COVID-19 Before and During the Period of SARS-CoV-2 B.1.617.2 (Delta) Predominance - COVID-NET, 14 States, January-August 2021
    Taylor, Christopher A.
    Patel, Kadam
    Pham, Huong
    Whitaker, Michael
    Anglin, Onika
    Kambhampati, Anita K.
    Milucky, Jennifer
    Chai, Shua J.
    Kirley, Pam Daily
    Alden, Nisha B.
    Armistead, Isaac
    Meek, James
    Yousey-Hindes, Kimberly
    Anderson, Evan J.
    Openo, Kyle P.
    Teno, Kenzie
    Weigel, Andy
    Monroe, Maya L.
    Ryan, Patricia A.
    Henderson, Justin
    Nunez, Val Tellez
    Bye, Erica
    Lynfield, Ruth
    Poblete, Mayvilynne
    Smelser, Chad
    Barney, Grant R.
    Spina, Nancy L.
    Bennett, Nancy M.
    Popham, Kevin
    Billing, Laurie M.
    Shiltz, Eli
    Abdullah, Nasreen
    Sutton, Melissa
    Schaffner, William
    Talbot, H. Keipp
    Ortega, Jake
    Price, Andrea
    Garg, Shikha
    Havers, Fiona P.
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2021, 70 (43): : 1513 - 1519
  • [6] Risk of severe clinical outcomes among persons with SARS-CoV-2 infection with differing levels of vaccination during widespread Omicron (B.1.1.529) and Delta (B.1.617.2) variant circulation in Northern California: A retrospective cohort study
    Skarbinski, Jacek
    Wood, Mariah S.
    Chervo, Tyler C.
    Schapiro, Jeffrey M.
    Elkin, Eric P.
    Valice, Emily
    Amsden, Laura B.
    Hsiao, Crystal
    Quesenberry, Charles
    Corley, Douglas A.
    Kushi, Lawrence H.
    LANCET REGIONAL HEALTH-AMERICAS, 2022, 12
  • [7] The diversity in the clinical features of children hospitalized with COVID-19 during the nonvariant, Alpha (B.1.1.7), Delta (B.1.617.2), and Omicron (B.1.1.529) variant periods of SARS CoV-2: Caution for neurological symptoms in Omicron variant
    Sahin, Aslihan
    Karadag-Oncel, Eda
    Buyuksen, Osman
    Ekemen-Keles, Yildiz
    Ustundag, Gulnihan
    Elvan-Tuz, Aysegul
    Tasar, Selin
    Didinmez-Taskirdi, Elif
    Baykan, Muge
    Kara-Aksay, Ahu
    Yilmaz, Nisel
    Olgac-Dundar, Nihal
    Yilmaz, Dilek
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (03)
  • [8] Effectiveness of BNT162b2 COVID-19 vaccination in prevention of hospitalisations and severe disease in adults with SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) variant between June 2021 and July 2022: A prospective test negative case-control study
    Chatzilena, Anastasia
    Hyams, Catherine
    Challen, Rob
    Marlow, Robin
    King, Jade
    Adegbite, David
    Kinney, Jane
    Clout, Madeleine
    Maskell, Nick
    Oliver, Jennifer
    Danon, Leon
    Finn, Adam
    LANCET REGIONAL HEALTH-EUROPE, 2023, 25
  • [9] COVID-19-Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status-COVID-NET, 14 States, July 2021-January 2022
    Taylor, Christopher A.
    Whitaker, Michael
    Anglin, Onika
    Milucky, Jennifer
    Patel, Kadam
    Huong Pham
    Chai, Shua J.
    Alden, Nisha B.
    Yousey-Hindes, Kimberly
    Anderson, Evan J.
    Teno, Kenzie
    Reeg, Libby
    Como-Sabetti, Kathryn
    Bleecker, Molly
    Barney, Grant
    Bennett, Nancy M.
    Billing, Laurie M.
    Sutton, Melissa
    Talbot, H. Keipp
    McCaffrey, Keegan
    Havers, Fiona P.
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2022, 71 (12): : 466 - 473
  • [10] Effectiveness of COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Frontline Workers Before and During B.1.617.2 (Delta) Variant Predominance - Eight US Locations, December 2020-August 2021
    Fowlkes, Ashley
    Gaglani, Manjusha
    Groover, Kimberly
    Thiese, Matthew S.
    Tyner, Harmony
    Ellingson, Katherine
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2021, 70 (34): : 1167 - 1169
12